| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―May―11 |
Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure |
Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J. Favaloro |
| 2 |
[GO] |
2024―Apr―09 |
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom |
Deepa J. Arachchillage, Indika Rajakaruna, Mike Makris, Mike Laffan |
| 3 |
[GO] |
2024―Feb―23 |
Venous Thrombosis in Airborne Viral Infections: Is Coronavirus Disease 2019 now Any Different from Influenza? |
Giuseppe Lippi, Emmanuel J. Favaloro, Riccardo Nocini |
| 4 |
[GO] |
2023―Nov―20 |
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients |
Massimo Franchini, Arturo Casadevall, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Daniele Focosi |
| 5 |
[GO] |
2023―Oct―13 |
Trends (2020-2022) toward Reduced Prevalence of Postcoronavirus Disease Syndrome and Improved Quality of Life for Hospitalized Coronavirus Disease 2019 Patients with Severe Infection and Venous Thromboembolism |
Antonio Bozzani, Vittorio Arici, Guido Tavazzi, Franco Ragni, Francesco Mojoli, Elena Cavallini, Floris van Vugt, Sara Cutti, Silvia Figini, Alessandro Venturi, Antonio V. Sterpetti, Eloisa Arbustini |
| 6 |
[GO] |
2023―Sep―27 |
Congenital Bleeding Disorders and COVID-19-A Systematic Literature Review |
Akbar Dorgalaleh, Seyed Mehrab Safdari, Shadi Tabibian, Mahmood Shams, Ali Dabbagh, Azadeh Rezazadeh |
| 7 |
[GO] |
2023―Sep―25 |
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male |
Bingwen Eugene Fan, Shravan Sadasiv Mucheli, Yee Lin Tang, Enming Yong, Rinkoo Dalan, Christine Cheung, Barnaby Edward Young, David Chien Boon Lye, Linfa Wang, Chee Wah Tan, Kiat Hon Tony Lim, Christina Lai Lin Sum, Christian Aledia Gallardo, Dheepa Christopher, Bernard PuiLam Leung, Xin Rong Lim, Shiun Woei Wong, Yew Woon Chia, Vanessa Cui Lian Chong |
| 8 |
[GO] |
2023―Sep―25 |
What Role Does Microthrombosis Play in Long COVID? |
Toshiaki Iba, Jean M. Connors, Jerrold H. Levy |
| 9 |
[GO] |
2023―Jun―24 |
D-dimer in Coronavirus 2019: An Acute Phase Reactant? |
Claudia Minutti-Zanella, Moisés M. Gallardo-Pérez, Guillermo J. Ruiz-Argüelles |
| 10 |
[GO] |
2023―Jun―16 |
Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation |
Marco Vettori, Giovanni Carpenè, Gian Luca Salvagno, Matteo Gelati, Francesco Dima, Giovanni Celegon, Emmanuel J. Favaloro, Giuseppe Lippi |
| 11 |
[GO] |
2023―May―19 |
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis |
Simone Turner, Caitlin A. Naidoo, Thomas J. Usher, Arneaux Kruger, Chantelle Venter, Gert J. Laubscher, M Asad Khan, Douglas B. Kell, Etheresia Pretorius |
| 12 |
[GO] |
2023―Mar―20 |
The Post-Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice |
Cindy M. M. de Jong, Gudula J.A.M. Boon, Y. N. Jenny Le, Stefano Barco, Bob Siegerink, Frederikus A. Klok |
| 13 |
[GO] |
2023―Feb―21 |
Association between Severe Acute Respiratory Syndrome Coronavirus 2Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment |
Marta Monti, Tiziano Martini, Vittorio Pengo, Giovanni Poletti, Paola Pedrazzi, Chiara Biasoli, Maddalena Giovacchini, Tommaso Fasano |
| 14 |
[GO] |
2023―Feb―14 |
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients |
Samuel Sherng Young Wang, Keefe Chee, Shiun Woei Wong, Guat Bee Tan, Hong Ang, Bernard PuiLam Leung, Chuen Wen Tan, Kollengode Ramanathan, Rinkoo Dalan, Christine Cheung, David Chien Lye, Barnaby Edward Young, Eng Soo Yap, Yew Woon Chia, Bingwen Eugene Fan |
| 15 |
[GO] |
2023―Jan―24 |
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic? |
Giuseppe Lippi, Valeria Perilli |
| 16 |
[GO] |
2023―Jan―05 |
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part IV |
Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi |
| 17 |
[GO] |
2023―Jan―05 |
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications |
Ali Zidan, Abdelrahman Noureldin, Shreya Anil Kumar, Abdelrahman Elsebaie, Maha Othman |
| 18 |
[GO] |
2022―Nov―06 |
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies |
Robin Arcani, Raphaël Cauchois, Pierre Suchon, Samuel Weber, Rodolphe Jean, Pierre-André Jarrot, Louise Rey, Geoffroy Venton, Marie Koubi, Romain Muller, Daniel Bertin, Jean-Louis Mège, Gilles Kaplanski, Nathalie Bardin |
| 19 |
[GO] |
2022―Oct―12 |
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment |
Luis Ortega-Paz, Azita H. Talasaz, Parham Sadeghipour, Tatjana S. Potpara, Herbert D. Aronow, Luis Jara-Palomares, Michelle Sholzberg, Dominick J. Angiolillo, Gregory Y.H. Lip, Behnood Bikdeli |
| 20 |
[GO] |
2022―Sep―29 |
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients |
Johannes Bösch, Christopher Rugg, Volker Schäfer, Philipp Lichtenberger, Nikolai Staier, Benjamin Treichl, Sasa Rajsic, Andreas Peer, Wolfgang Schobersberger, Dietmar Fries, Mirjam Bachler |
| 21 |
[GO] |
2022―Sep―29 |
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness |
Adam Cuker |
| 22 |
[GO] |
2022―Sep―29 |
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness |
Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, Este M. Burger, Gert J. Laubscher, Tongai G. Maponga, Maritha J. Kotze, Hau C. Kwaan, Joseph B. Miller, Daniel Fulkerson, Wei Huff, Eric Chang, Grant Wiarda, Connor M. Bunch, Mark M. Walsh, Syed Raza, Mahmud Zamlut, Hunter B. Moore, Ernest E. Moore, Matthew D. Neal, Douglas B. Kell, Etheresia Pretorius |
| 23 |
[GO] |
2022―Sep―02 |
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus? |
Giuseppe Lippi, Emmanuel J. Favaloro |
| 24 |
[GO] |
2022―Sep―02 |
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients |
John G. Rizk, Carl J. Lavie, Brandon Michael Henry |
| 25 |
[GO] |
2022―Sep―02 |
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review |
Massimo Franchini, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Ugo Moretti, Daniele Focosi, Marco Tuccori |
| 26 |
[GO] |
2022―Jul―08 |
D-dimers-“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19 |
Jecko Thachil, Emmanuel J. Favaloro, Giuseppe Lippi |
| 27 |
[GO] |
2022―Jul―06 |
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis |
Matteo Candeloro, Sam Schulman |
| 28 |
[GO] |
2022―Jun―27 |
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine? |
Allison C. Y. Tso, Kiat H. Ong, Christina L. L. Sum, Bingwen E. Fan, Grace Y. L. Chan, Dheepa Christopher, Hwee S. Howe, Yi W. Lai, Xin R. Lim, Bernard P. L. Leung |
| 29 |
[GO] |
2022―Jun―23 |
Platelet Activation and Thrombosis in COVID-19 |
Toshiaki Iba, Hideo Wada, Jerrold H. Levy |
| 30 |
[GO] |
2022―Jun―23 |
Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients |
John G. Rizk, Jose G. Lazo, Aashish Gupta, Carl J. Lavie, Mark B. Effron |
| 31 |
[GO] |
2022―Jun―21 |
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment |
Domenico Benvenuto, Sergio Carnevale, Marta Giovanetti, Massimo Ciccozzi, Francesco Broccolo |
| 32 |
[GO] |
2022―Apr―25 |
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years |
John G. Rizk, Aashish Gupta, Jose G. Lazo, Partha Sardar, Brandon Michael Henry, Carl J. Lavie, Mark B. Effron |
| 33 |
[GO] |
2022―Apr―22 |
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 34 |
[GO] |
2022―Mar―08 |
Aspirin use Reduces Platelet Hyperreactivity and Degranulation in COVID-19 Patients |
Younes Zaid, Qamar Lahlimi, Loubna Khalki, Nabil Zaid, Mounia Oudghiri, Amine Cheikh, Abdallah Naya, Yahye Merhi, Fadila Guessous |
| 35 |
[GO] |
2022―Feb―15 |
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties |
Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro |
| 36 |
[GO] |
2022―Feb―01 |
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III |
Emmanuel J. Favaloro, Giuseppe Lippi |
| 37 |
[GO] |
2022―Jan―12 |
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19 |
Giuseppe Lippi, Emmanuel J. Favaloro |
| 38 |
[GO] |
2022―Jan―12 |
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients? |
Sergio Carnevale, Marta Giovanetti, Domenico Benvenuto, Massimo Ciccozzi, Francesco Broccolo |
| 39 |
[GO] |
2021―Dec―14 |
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings |
Giacomo Buso, Lucia Mazzolai, José Antonio Rueda-Camino, Carmen Fernández-Capitán, David Jiménez, Behnood Bikdeli, José Luis Lobo, José Luis Fernández-Reyes, Maurizio Ciammaichella, Manuel Monreal |
| 40 |
[GO] |
2021―Oct―29 |
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study |
Christine Lodberg Hvas, Julie Brogaard Larsen, Kasper Adelborg, Steffen Christensen, Anne-Mette Hvas |
| 41 |
[GO] |
2021―Oct―25 |
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19 |
Mehran Bahraini, Akbar Dorgalaleh |
| 42 |
[GO] |
2021―Oct―25 |
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More |
Giuseppe Lippi, Emmanuel J. Favaloro |
| 43 |
[GO] |
2021―Oct―10 |
COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation |
Jecko Thachil |
| 44 |
[GO] |
2021―Sep―24 |
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19) |
Federico Chiurazzi, Antonella Tufano, Maria Esposito, Francesco D'Agostino, Aniello Casoria, Filomena Capasso, Giovanni Di Minno |
| 45 |
[GO] |
2021―Aug―13 |
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19 |
Peter Poredos, Pavel Poredos |
| 46 |
[GO] |
2021―Aug―13 |
Impact of Thrombosis and Bleeding in Patients with Severe COVID-19 versus Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation |
Anna Weatherill, Mike Laffan, Mihaela Gasper, Paolo Bianchi, Maurizio Passariello, Suveer Singh, James Doyle, Brijesh Patel, Stephane Ledot, Benjamin Garfield, Deepa J. Arachchillage |
| 47 |
[GO] |
2021―Aug―13 |
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series |
Veronica Abate, Aniello Casoria, Ferruccio Galletti, Giovanni Di Minno, Domenico Rendina, Riccardo Muscariello, Vincenzo Nuzzo, Maria Vargas, Giuseppe Servillo, Pietro Venetucci, Paolo Conca, Antonella Tufano |
| 48 |
[GO] |
2021―Jun―15 |
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? |
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi |
| 49 |
[GO] |
2021―Jun―15 |
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature |
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi |
| 50 |
[GO] |
2021―Jun―01 |
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II |
Emmanuel J. Favaloro, Giuseppe Lippi |
| 51 |
[GO] |
2021―May―10 |
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation |
Youness Limami, Loubna Khalki, Nabil Zaid, Meriem Khyatti, Joumana El Turk, Mounia Ammara, El Mostafa Mtairag, Mounia Oudghiri, Abdallah Naya, Mustapha Taberkant, Younes Zaid |
| 52 |
[GO] |
2021―May―07 |
Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19) |
Serafino Fazio, Antonella Tufano, Giovanni de Simone |
| 53 |
[GO] |
2021―Apr―24 |
Mean Platelet Volume Predicts Severe COVID-19 Illness |
Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro |
| 54 |
[GO] |
2021―Apr―24 |
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization |
Matthias M. Engelen, Christophe Vandenbriele, Tim Balthazar, Eveline Claeys, Jan Gunst, Ipek Guler, Marc Jacquemin, Stefan Janssens, Natalie Lorent, Laurens Liesenborghs, Kathelijne Peerlinck, Griet Pieters, Steffen Rex, Pieter Sinonquel, Lorenz Van der Linden, Christine Van Laer, Robin Vos, Joost Wauters, Alexander Wilmer, Peter Verhamme, Thomas Vanassche |
| 55 |
[GO] |
2021―Apr―24 |
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis |
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi |
| 56 |
[GO] |
2021―Apr―16 |
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger |
Bingwen Eugene Fan, Christine Cheung |
| 57 |
[GO] |
2021―Apr―14 |
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis |
Roberta Parisi, Simona Costanzo, Augusto Di Castelnuovo, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello |
| 58 |
[GO] |
2021―Apr―14 |
Platelet Function in Viral Immunity and SARS-CoV-2 Infection |
Afaf Allaoui, Akif A. Khawaja, Oussama Badad, Mariam Naciri, Marie Lordkipanidzé, Fadila Guessous, Younes Zaid |
| 59 |
[GO] |
2021―Feb―20 |
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage |
John E. Stillson, Connor M. Bunch, Laura Gillespie, Rashid Khan, Meredith Wierman, Joseph Pulvirenti, Htay Phyu, Stephen Anderson, Mahmoud Al-Fadhl, Anthony V. Thomas, Hau C. Kwaan, Ernest Moore, Hunter Moore, Mark M. Walsh |
| 60 |
[GO] |
2021―Jan―23 |
Efficacy Safety and of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19) |
Abdul A. Shlebak, Mike Laffan, Deepa R. J. Arachchillage, Christine Shi, David Saliu, Peter Kozman, Emma Mi, Noora Buti, Elika Kashef, Susan J. Copley, Carlos Gomez, Richard Leonard, Riaz Aziz |
| 61 |
[GO] |
2021―Jan―23 |
Does COVID-19 Provide a Clue for Thrombosis in ITP? |
Jecko Thachil |
| 62 |
[GO] |
2021―Jan―23 |
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-analysis |
Mairi Pucci, Diletta Onorato, Giovanni Carpene, Brandon Michael Henry, Fabian Sanchis-Gomar, Giuseppe Lippi |
| 63 |
[GO] |
2021―Jan―23 |
Thrombin Generation in Patients with Coronavirus Disease 2019 |
Marco Benati, Gian Luca Salvagno, Simone De Nitto, Matteo Gelati, Barbara Lavorgna, Cristiano Fava, Pietro Minuz, Giuseppe Lippi |
| 64 |
[GO] |
2021―Jan―23 |
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study |
Brandon Michael Henry, Isaac Cheruiyot, Justin L. Benoit, Giuseppe Lippi, Zoltán Prohászka, Emmanuel J. Favaloro, Stefanie W. Benoit |
| 65 |
[GO] |
2021―Jan―12 |
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly |
Yona Nadir, Benjamin Brenner |
| 66 |
[GO] |
2020―Dec―31 |
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness |
Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar |
| 67 |
[GO] |
2020―Dec―31 |
Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase |
Armando Caballero López, Carlos Herrera Cartaya, Elibet Chávez González, Delvis González Reinoso, Jorge Alain Caballero Font, Naivi Sánchez Vera, Mario E. Nápoles Lizano, Alexander Vázquez Roque, Alexis Morales Valdera, Tania Crombet Ramos, Julio Betancourt Cervantes |
| 68 |
[GO] |
2020―Dec―18 |
Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series |
Samia Kazmi, Fivzia Herekar, Samreen Sarfaraz |
| 69 |
[GO] |
2020―Oct―21 |
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19 |
Carmen Fernández-Capitán, Raquel Barba, María del Carmen Díaz-Pedroche, Patricia Sigüenza, Pablo Demelo-Rodriguez, Carmine Siniscalchi, José María Pedrajas, Ana I. Farfán-Sedano, Pavel Eduardo Olivera, Covadonga Gómez-Cuervo, Pilar Llamas, Paula Villares, Olivier Sanchez, Raquel López-Reyes, Judith Catella, Behnood Bikdeli, Ido Weinberg, Alfonso J. Tafur, David Jiménez, Manuel Monreal |
| 70 |
[GO] |
2020―Oct―20 |
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I |
Emmanuel J. Favaloro, Giuseppe Lippi |
| 71 |
[GO] |
2020―Sep―04 |
Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation |
Guy J. Padley, Shivani S. Desai, Chrissy Weaver, Laura C. Price, Deepa J. Arachchillage, Carole A. Ridge |
| 72 |
[GO] |
2020―Sep―03 |
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19) |
Iván Parra-Izquierdo, Joseph E. Aslan |
| 73 |
[GO] |
2020―Sep―03 |
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19) |
Brandon Michael Henry, Stefanie W. Benoit, Jonathan Hoehn, Giuseppe Lippi, Emmanuel J. Favaloro, Justin L. Benoit |
| 74 |
[GO] |
2020―Sep―03 |
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis |
Jecko Thachil, Ton Lisman |
| 75 |
[GO] |
2020―Sep―03 |
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? |
Job Harenberg, Rupert Bauersachs, Walter Ageno |
| 76 |
[GO] |
2020―Sep―03 |
COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination |
Ariunzaya Amgalan, Ann Kinga Malinowski, Maha Othman |
| 77 |
[GO] |
2020―Sep―03 |
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies |
Alessandro Di Minno, Pasquale Ambrosino, Ilenia Calcaterra, Matteo Nicola Dario Di Minno |
| 78 |
[GO] |
2020―Sep―03 |
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes |
Emma Kate Zadow, Daniel William Taylor Wundersitz, Diane Louise Hughes, Murray John Adams, Michael Ian Charles Kingsley, Hilary Anne Blacklock, Sam Shi Xuan Wu, Amanda Clare Benson, Frédéric Dutheil, Brett Ashley Gordon |
| 79 |
[GO] |
2020―Sep―02 |
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) |
Devis Benfaremo, Elisa Fustini, Silvia Gennarini, Massimo Mattioli |
| 80 |
[GO] |
2020―Sep―02 |
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19) |
Bianca Christensen, Emmanuel J. Favaloro, Giuseppe Lippi, Elizabeth M. Van Cott |
| 81 |
[GO] |
2020―Sep―02 |
Immune-Mediated Coagulopathy in COVID-19 Infection |
Zahava Vadasz, Benjamin Brenner, Elias Toubi |
| 82 |
[GO] |
2020―Aug―21 |
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19 |
Ashkan Hashemi, Mahesh V. Madhavan, Behnood Bikdeli |
| 83 |
[GO] |
2020―Aug―12 |
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19 |
Netanel A. Horowitz, Benjamin Brenner |
| 84 |
[GO] |
2020―Jun―18 |
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? |
Akbar Dorgalaleh, Ali Dabbagh, Shadi Tabibian, Mohammad Reza Baghaeipour, Mohammad Jazebi, Mehran Bahraini, Sahar Fazeli, Fariba Rad, Nazanin Baghaeipour |
| 85 |
[GO] |
2020―Jun―11 |
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection |
Steven de Maat, Quirijn de Mast, A.H. Jan Danser, Frank L. van de Veerdonk, Coen Maas |
| 86 |
[GO] |
2020―Jun―11 |
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma |
Paul F. Lindholm, Glenn Ramsey, Hau C. Kwaan |
| 87 |
[GO] |
2020―Jun―08 |
Bleeding and Bleeding Risk in COVID-19 |
Akbar Dorgalaleh |
| 88 |
[GO] |
2020―Jun―08 |
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19 |
Massimo Franchini, Claudia Del Fante, Catherine Klersy, Claudia Glingani, Elena Percivalle, Fausto Baldanti, Cesare Perotti |
| 89 |
[GO] |
2020―Jun―08 |
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders |
Antonio Coppola, Annarita Tagliaferri, Gianna Franca Rivolta, Gabriele Quintavalle, Massimo Franchini |
| 90 |
[GO] |
2020―Jun―08 |
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both |
Marcel Levi, Jecko Thachil |
| 91 |
[GO] |
2020―May―12 |
SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? |
Jecko Thachil, Alok Srivastava |
| 92 |
[GO] |
2020―May―11 |
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism |
Sam Schulman |
| 93 |
[GO] |
2020―May―09 |
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae |
Hau C. Kwaan |
| 94 |
[GO] |
2020―May―01 |
Platelets in Coronavirus Disease 2019 |
Julie Brogaard Larsen, Leonardo Pasalic, Anne-Mette Hvas |
| 95 |
[GO] |
2020―Apr―12 |
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring |
Emmanuel J. Favaloro, Giuseppe Lippi |
